Evaluation of the use of apixaban in prevention of thromboembolic disease in patients with myeloma treated with iMiDs

被引：0
|
作者：
Gavard, M. [1 ]
Pegourie, B. [2 ]
Pernod, G. [3 ]
Rolland-Neyret, V. [2 ]
机构：
[1] CHU Grenoble Alpes, Delegat Rech Clin & Innovat, Grenoble, France
[2] CHU Grenoble Alpes, Serv Hematol, Grenoble, France
[3] CHU Grenoble Alpes, Serv Med Vasc, Grenoble, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PM2 - 044
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [41] Prevention and treatment of venous thromboembolic disease complications in primary hip arthroplasty patients
    Paiement, GD
    INSTRUCTIONAL COURSE LECTURES, VOL 47 - 1998, 1998, 47 : 331 - 335
  • [42] Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
    Garcia, David A.
    Wallentin, Lars
    Lopes, Renato D.
    Thomas, Laine
    Alexander, John H.
    Hylek, Elaine M.
    Ansell, Jack
    Hanna, Michael
    Lanas, Fernando
    Flaker, Greg
    Commerford, Patrick
    Xavier, Denis
    Vinereanu, Dragos
    Yang, Hongqiu
    Granger, Christopher B.
    AMERICAN HEART JOURNAL, 2013, 166 (03) : 549 - 558
  • [43] Venous thromboembolic disease in cancer patients treated with immunotherapy: analysis of the TESEO study
    Ortega Moran, L.
    Sanchez Canovas, M.
    Perez Altozano, J.
    Teijeira Sanchez, L.
    Cumplido Buron, J. D.
    Gallardo Diaz, E.
    Antonio Rebollo, M.
    Ceballos Barbancho, E.
    Martinez Lago, N.
    Ortiz Morales, M. J.
    Castellon Rubio, V. E.
    Carmona Bayonas, A.
    Jimenez Fonseca, P.
    Martinez de Castro, E.
    Munoz Langa, J.
    Perez Segura, P.
    Munoz Martin, A.
    THROMBOSIS RESEARCH, 2021, 200 : S50 - S50
  • [44] Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?
    Pelzer, U.
    Sinn, M.
    Stieler, J.
    Riess, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (41) : 2084 - 2088
  • [45] Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Avezum, Alvaro
    Lopes, Renato D.
    Schulte, Phillip J.
    Lanas, Fernando
    Gersh, Bernard J.
    Hanna, Michael
    Pais, Prem
    Erol, Cetin
    Diaz, Rafael
    Cecilia Bahit, M.
    Bartunek, Jozef
    De Caterina, Raffaele
    Goto, Shinya
    Ruzyllo, Witold
    Zhu, Jun
    Granger, Christopher B.
    Alexander, John H.
    CIRCULATION, 2015, 132 (08) : 624 - 632
  • [46] Primary Prevention Apixaban vs. Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease
    Diener, H. C.
    AKTUELLE NEUROLOGIE, 2016, 43 (06) : E36 - E36
  • [47] PREVENTION OF OSTEONECROSIS OF THE JAW DURING ZOLENDRONAT USE IN THE PATIENTS WITH MULTIPLE MYELOMA
    Pour, L.
    Machalka, M.
    Fojtik, Z.
    Adam, Z.
    Krejci, M.
    Sandecka, V.
    Pokorny, P.
    Perina, V.
    Krivanova, A.
    Zahradova, L.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 25 - 26
  • [48] The Use of Dabigatran for Prevention of Thromboembolic Complications in Patients Underwent Atrial Fibrillation Catheter Ablation
    Mamchur, S. E.
    Gorbunova, E. V.
    Sherbinina, D. A.
    Romanova, M. P.
    KARDIOLOGIYA, 2015, 55 (04) : 30 - 35
  • [49] LOW INCIDENCE OF THROMBOEMBOLIC DISEASE - AN EVALUATION OF OBSTETRIC AND GYNECOLOGIC PATIENTS IN ISTANBUL
    EREZ, N
    BABUNA, C
    UNER, A
    OBSTETRICS AND GYNECOLOGY, 1966, 27 (06): : 833 - &
  • [50] Use of direct oral anticoagulants for the prevention and treatment of thromboembolic disease in patients with reduced renal function: a short review of the clinical evidence
    Willett, Kristine C.
    Morrill, Amanda M.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 447 - 454
12345